PRIMA-1 and PRIMA-1(Met) (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies

por Perdrix, Anne, Najem, Ahmad, Saussez, Sven, Awada, Ahmad, Journe, Fabrice, Ghanem, Ghanem, Krayem, Mohammad
Publicado 2017

Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer

por Anderson, Richard A., Kelsey, Tom W., Perdrix, Anne, Olympios, Nathalie, Duhamel, Orianne, Lambertini, Matteo, Clatot, Florian
Publicado 2022

Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients

por Allouchery, Violette, Beaussire, Ludivine, Perdrix, Anne, Sefrioui, David, Augusto, Laetitia, Guillemet, Cécile, Sarafan-Vasseur, Nasrin, Di Fiore, Frédéric, Clatot, Florian
Publicado 2018

Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma

por Drouyer, Aurélien, Beaussire, Ludivine, Jorda, Pauline, Leheurteur, Marianne, Guillemet, Cécile, Berghian, Anca, Georgescu, Dragos, Di Fiore, Frédéric, Perdrix, Anne, Clatot, Florian
Publicado 2023

Effects of Vitamin A on In Vitro Maturation of Pre-Pubertal Mouse Spermatogonial Stem Cells

por Travers, Albanne, Arkoun, Brahim, Safsaf, Athmane, Milazzo, Jean-Pierre, Absyte, Anne, Bironneau, Amandine, Perdrix, Anne, Sibert, Louis, Macé, Bertrand, Cauliez, Bruno, Rives, Nathalie
Publicado 2013

Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclo...

por Lambertini, Matteo, Olympios, Nathalie, Lequesne, Justine, Calbrix, Céline, Fontanilles, Maxime, Loeb, Agnès, Leheurteur, Marianne, Demeestere, Isabelle, Di Fiore, Frédéric, Perdrix, Anne, Clatot, Florian
Publicado 2019

Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients

por Allouchery, Violette, Perdrix, Anne, Calbrix, Céline, Berghian, Anca, Lequesne, Justine, Fontanilles, Maxime, Leheurteur, Marianne, Etancelin, Pascaline, Sarafan-Vasseur, Nasrin, Di Fiore, Frédéric, Clatot, Florian
Publicado 2021

Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer

por Clatot, Florian, Perdrix, Anne, Beaussire, Ludivine, Lequesne, Justine, Lévy, Christelle, Emile, George, Bubenheim, Michael, Lacaille, Sigrid, Calbrix, Céline, Augusto, Laetitia, Guillemet, Cécile, Alexandru, Cristina, Fontanilles, Maxime, Sefrioui, David, Burel, Lucie, Guénot, Sabine, Richard, Doriane, Sarafan-Vasseur, Nasrin, Di Fiore, Frédéric
Publicado 2020

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours

por Sefrioui, David, Blanchard, France, Toure, Emmanuel, Basile, Paul, Beaussire, Ludivine, Dolfus, Claire, Perdrix, Anne, Paresy, Marianne, Antonietti, Michel, Iwanicki-Caron, Isabelle, Alhameedi, Raied, Lecleire, Stephane, Gangloff, Alice, Schwarz, Lilian, Clatot, Florian, Tuech, Jean-Jacques, Frébourg, Thierry, Jardin, Fabrice, Sabourin, Jean-Christophe, Sarafan-Vasseur, Nasrin, Michel, Pierre, Di Fiore, Frédéric
Publicado 2017

Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor

por Clatot, Florian, Perdrix, Anne, Augusto, Laetitia, Beaussire, Ludivine, Delacour, Julien, Calbrix, Céline, Sefrioui, David, Viailly, Pierre-Julien, Bubenheim, Michael, Moldovan, Cristian, Alexandru, Cristina, Tennevet, Isabelle, Rigal, Olivier, Guillemet, Cécile, Leheurteur, Marianne, Gouérant, Sophie, Petrau, Camille, Théry, Jean-Christophe, Picquenot, Jean-Michel, Veyret, Corinne, Frébourg, Thierry, Jardin, Fabrice, Sarafan-Vasseur, Nasrin, Di Fiore, Frédéric
Publicado 2016